323 related articles for article (PubMed ID: 15705418)
1. Adenosine deaminase deficiency: metabolic basis of immune deficiency and pulmonary inflammation.
Blackburn MR; Kellems RE
Adv Immunol; 2005; 86():1-41. PubMed ID: 15705418
[TBL] [Abstract][Full Text] [Related]
2. The importance of adenosine deaminase for lymphocyte development and function.
Aldrich MB; Blackburn MR; Kellems RE
Biochem Biophys Res Commun; 2000 Jun; 272(2):311-5. PubMed ID: 10833410
[TBL] [Abstract][Full Text] [Related]
3. Function of murine adenosine deaminase in the gastrointestinal tract.
Xu PA; Kellems RE
Biochem Biophys Res Commun; 2000 Mar; 269(3):749-57. PubMed ID: 10720488
[TBL] [Abstract][Full Text] [Related]
4. New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency.
Hershfield MS
Eur J Immunol; 2005 Jan; 35(1):25-30. PubMed ID: 15580654
[TBL] [Abstract][Full Text] [Related]
5. Adenosine-mediated mast cell degranulation in adenosine deaminase-deficient mice.
Zhong H; Chunn JL; Volmer JB; Fozard JR; Blackburn MR
J Pharmacol Exp Ther; 2001 Aug; 298(2):433-40. PubMed ID: 11454903
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow gene therapy for adenosine deaminase deficiency.
Kaptein LC; Einerhand MP; Braakman E; Valerio D; van Beusechem VW
Immunodeficiency; 1993; 4(1-4):335-45. PubMed ID: 7909479
[TBL] [Abstract][Full Text] [Related]
7. The use of enzyme therapy to regulate the metabolic and phenotypic consequences of adenosine deaminase deficiency in mice. Differential impact on pulmonary and immunologic abnormalities.
Blackburn MR; Aldrich M; Volmer JB; Chen W; Zhong H; Kelly S; Hershfield MS; Datta SK; Kellems RE
J Biol Chem; 2000 Oct; 275(41):32114-21. PubMed ID: 10908569
[TBL] [Abstract][Full Text] [Related]
8. A 9-yr evaluation of carrier erythrocyte encapsulated adenosine deaminase (ADA) therapy in a patient with adult-type ADA deficiency.
Bax BE; Bain MD; Fairbanks LD; Webster AD; Ind PW; Hershfield MS; Chalmers RA
Eur J Haematol; 2007 Oct; 79(4):338-48. PubMed ID: 17680812
[TBL] [Abstract][Full Text] [Related]
9. Adenosine deaminase deficiency: clinical expression, molecular basis, and therapy.
Hershfield MS
Semin Hematol; 1998 Oct; 35(4):291-8. PubMed ID: 9801258
[TBL] [Abstract][Full Text] [Related]
10. Adenosine-deaminase-deficient mice die perinatally and exhibit liver-cell degeneration, atelectasis and small intestinal cell death.
Migchielsen AA; Breuer ML; van Roon MA; te Riele H; Zurcher C; Ossendorp F; Toutain S; Hershfield MS; Berns A; Valerio D
Nat Genet; 1995 Jul; 10(3):279-87. PubMed ID: 7670465
[TBL] [Abstract][Full Text] [Related]
11. Adenosine deaminase-deficient mice generated using a two-stage genetic engineering strategy exhibit a combined immunodeficiency.
Blackburn MR; Datta SK; Kellems RE
J Biol Chem; 1998 Feb; 273(9):5093-100. PubMed ID: 9478961
[TBL] [Abstract][Full Text] [Related]
12. Adenosine deaminase deficiency.
Hirschhorn R
Immunodefic Rev; 1990; 2(3):175-98. PubMed ID: 2078332
[TBL] [Abstract][Full Text] [Related]
13. In vivo transduction by intravenous injection of a lentiviral vector expressing human ADA into neonatal ADA gene knockout mice: a novel form of enzyme replacement therapy for ADA deficiency.
Carbonaro DA; Jin X; Petersen D; Wang X; Dorey F; Kil KS; Aldrich M; Blackburn MR; Kellems RE; Kohn DB
Mol Ther; 2006 Jun; 13(6):1110-20. PubMed ID: 16651028
[TBL] [Abstract][Full Text] [Related]
14. [Deficiency of adenosine desaminase (ADA): clinical, biochemical, molecular and treatment aspects].
Tintos-Hernández JA; Dávalos-Rodríguez IP
Rev Invest Clin; 2011; 63(1):75-83. PubMed ID: 21585012
[TBL] [Abstract][Full Text] [Related]
15. Severe combined immunodeficiency of reduced severity due to homozygosity for an adenosine deaminase missense mutation (Arg253Pro).
Hirschhorn R; Yang DR; Insel RA; Ballow M
Cell Immunol; 1993 Dec; 152(2):383-93. PubMed ID: 8258146
[TBL] [Abstract][Full Text] [Related]
16. [Immune insufficiency in enzyme defects of purine metabolism].
Müller G
Z Gesamte Inn Med; 1983 Feb; 38(3):83-9. PubMed ID: 6303005
[TBL] [Abstract][Full Text] [Related]
17. Generation of normal lymphocyte populations following transplantation of adenosine-deaminase-deficient fetal liver cells.
Migchielsen AA; Knaän-Schanzer S; Breuer ML; Hershfield MS; Valerio D
Bone Marrow Transplant; 1997 Jun; 19(11):1137-43. PubMed ID: 9193758
[TBL] [Abstract][Full Text] [Related]
18. Normal and mutant human adenosine deaminase genes.
Akeson AL; Wiginton DA; Hutton JJ
J Cell Biochem; 1989 Mar; 39(3):217-28. PubMed ID: 2651461
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of biochemical, clinical and immunological parameters in severe combined immunodeficiency due to adenosine deaminase deficiency.
Morgan G; Levinsky RJ; Hugh-Jones K; Fairbanks LD; Morris GS; Simmonds HA
Clin Exp Immunol; 1987 Dec; 70(3):491-9. PubMed ID: 3436096
[TBL] [Abstract][Full Text] [Related]
20. Severe combined immune deficiency in an adenosine deaminase-deficient patient.
Ozdemir O
Allergy Asthma Proc; 2006; 27(2):172-4. PubMed ID: 16724639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
